DNAViruses 421
theintercellularspace,thusremainingbeyondthereachoftheimmune
defenses.Possiblecomplicationsincludekeratoconjunctivitisandahighly
lethalformofencephalitis.
TheinitialinfectionwithHSVtype 2 normallyaffectstheurogenitalarea
(“genitaltype”)andcanbecontracteddespiteanexistingHSVtype 1 infec-
tion.HSVtype 2 persistsinthelatentstateinthelumbosacralgangliaorper-
ipheraltissues,fromwhereitcausesepisodesofmanifestherpesgenitalis.
NeurologicalcomplicationsareveryrareandmorebenignthaninHSV
type 1 .Ontheotherhand,infectionsofnewbornchildren(herpesneonator-
um),e.g.,incasesofmaternalgenitalherpes,arefearedfortheirhighlethality
rate.
Diagnosis.Cultivatingthepathogenfrompustulecontentsisthemethodof
choiceinlabialandgenitalherpes.InanHSVencephalitis,thecerebrospinal
fluidwillcontainfewvirusesornoneatall.Insuchcases,theycanonlybe
cultivatedfromtissues(biopsyorautopsymaterial).Virusdetectionby
meansofcerebrospinalfluidPCRisworthatry.
Directdetectionofthevirusesunderanelectronmicroscopeisonlyprac-
ticableifthespecimencontainslargenumbersofviruses,whichinpractice
willnormallyonlybethecaseinblistercontents.Theviruscanalsobede-
tecteddirectlyinpatientspecimensusingimmunofluorescenceorin-situ
hybridization(p.408),butthematerialmustcontainvirus-infectedcells,
i.e.,blistercontentsarenotassuitablehereasinelectronmicroscopyand
virusisolation.
SerologicalinvestigationresultsinHSVlacksignificanceduetothehigh
levelofgeneralcontaminationinthepopulation.
Epidemiology,prevention,andtherapy.HSVtype 1 istransmittedby
contact,andpossiblybysmearinfectionaswell.ContaminationwithHSV
thereforebeginsinearlychildhood.TransmissionofHSVtype 2 usuallyoc-
cursduringsexualintercourse,sothatinfectionsaregenerallynotobserved
untilafterpuberty.Noimmuneprophylaxis(vaccination)iscurrentlyavail-
ableforHSV.Acycloguanosineisusedprophylacticallyinimmunosuppressed
patients(seeChapter 7 ,p. 40 4).
Specifictherapyispossiblewithacycloguanosine.Usedintime,thische-
motherapycansavelivesinHSVencephalitis.
Varicella-zosterVirus(VZV)
Pathogen,pathogenesis,clinicalpicture.TheVZvirusdifferssubstantially
fromHSV,bothserologicallyandinmanybiologicaltraits.Forinstance,itcan
onlybegrowninprimatecellcultures,inwhichitgrowsmuchmoreslowly
andmorecell-associatedthanisthecasewithHSV.Nosubtypeshavebeen
described.
8
Kayser, Medical Microbiology © 2005 Thieme